Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000872904 | SCV001014795 | likely benign | Deficiency of hydroxymethylglutaryl-CoA lyase | 2024-12-04 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004711340 | SCV005261375 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV000872904 | SCV001467215 | uncertain significance | Deficiency of hydroxymethylglutaryl-CoA lyase | 2020-08-25 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003908289 | SCV004731642 | likely benign | HMGCL-related disorder | 2019-04-12 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |